This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
Aurora Cannabis was rising Tuesday after fiscal fourth-quarter sales missed analysts’ estimates but the Canadian cannabis company said cost savings should “clear a path” for being adjusted Ebitda positive.
Analysts at MKM Partners upgraded the stock to Neutral from Sell.
Sales in the period fell to C$54.8 million from C$68.4 million a year…